Treace Medical Concepts, Inc.
TMCI
$6.72
-$0.26-3.73%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.54% | 11.89% | 16.14% | 18.90% | 26.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.54% | 11.89% | 16.14% | 18.90% | 26.48% |
| Cost of Revenue | 11.74% | 16.80% | 20.16% | 24.49% | 31.04% |
| Gross Profit | 6.56% | 10.75% | 15.21% | 17.64% | 25.46% |
| SG&A Expenses | 1.26% | 8.21% | 17.83% | 26.26% | 29.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.12% | 11.09% | 18.99% | 26.30% | 29.23% |
| Operating Income | 7.72% | -8.18% | -29.34% | -55.97% | -39.72% |
| Income Before Tax | 3.21% | -12.55% | -29.09% | -50.66% | -15.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.21% | -12.55% | -29.09% | -50.66% | -15.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.21% | -12.55% | -29.09% | -50.66% | -15.91% |
| EBIT | 7.72% | -8.18% | -29.34% | -55.97% | -39.72% |
| EBITDA | 12.81% | -3.52% | -25.60% | -51.88% | -34.34% |
| EPS Basic | 4.28% | -10.20% | -25.15% | -41.65% | -5.90% |
| Normalized Basic EPS | 4.36% | -10.13% | -26.15% | -42.90% | -18.20% |
| EPS Diluted | 3.98% | -10.52% | -25.15% | -41.65% | -5.90% |
| Normalized Diluted EPS | 4.36% | -10.13% | -26.15% | -42.90% | -18.20% |
| Average Basic Shares Outstanding | 1.17% | 2.09% | 4.46% | 6.94% | 9.52% |
| Average Diluted Shares Outstanding | 1.17% | 2.09% | 4.46% | 6.94% | 9.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |